X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ADCOCK INGRAM
Jun-14
STERLING BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs11349-   
Low Rs3252-   
Sales per share (Unadj.) Rs26.8103.7-  
Earnings per share (Unadj.) Rs-15.0-26.1-  
Cash flow per share (Unadj.) Rs-5.5-21.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.981.4-  
Shares outstanding (eoy) m267.87168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 9.0%   
Avg P/E ratio x-0.5-11.5 4.0%  
P/CF ratio (eoy) x-1.3-13.9 9.2%  
Price / Book Value ratio x0.13.7 3.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86250,658 3.7%   
No. of employees `0001.44.3 31.5%   
Total wages/salary Rs m5473,179 17.2%   
Avg. sales/employee Rs Th5,303.34,078.4 130.0%   
Avg. wages/employee Rs Th403.8740.6 54.5%   
Avg. net profit/employee Rs Th-2,959.0-1,027.7 287.9%   
INCOME DATA
Net Sales Rs m7,18117,508 41.0%  
Other income Rs m43123 34.7%   
Total revenues Rs m7,22317,631 41.0%   
Gross profit Rs m947-3,034 -31.2%  
Depreciation Rs m2,543756 336.6%   
Interest Rs m4,377474 922.9%   
Profit before tax Rs m-5,931-4,141 143.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924259 -743.6%   
Profit after tax Rs m-4,007-4,412 90.8%  
Gross profit margin %13.2-17.3 -76.1%  
Effective tax rate %32.4-6.2 -519.3%   
Net profit margin %-55.8-25.2 221.4%  
BALANCE SHEET DATA
Current assets Rs m14,33512,823 111.8%   
Current liabilities Rs m49,8097,215 690.4%   
Net working cap to sales %-494.032.0 -1,542.2%  
Current ratio x0.31.8 16.2%  
Inventory Days Days403111 363.7%  
Debtors Days Days171124 137.7%  
Net fixed assets Rs m55,4327,475 741.6%   
Share capital Rs m26881 329.6%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,70113,742 107.0%   
Long term debt Rs m9,4784,829 196.3%   
Total assets Rs m73,98825,960 285.0%  
Interest coverage x-0.4-7.7 4.6%   
Debt to equity ratio x0.60.4 183.5%  
Sales to assets ratio x0.10.7 14.4%   
Return on assets %0.5-15.2 -3.3%  
Return on equity %-27.3-32.1 84.9%  
Return on capital %-6.4-19.8 32.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,7191,494 115.0%  
From Investments Rs m-3,148-459 686.1%  
From Financial Activity Rs m1,4264,383 32.5%  
Net Cashflow Rs m-35,418 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.81 Rs / ZAR

Compare STERLING BIOTECH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: MERCK  AUROBINDO PHARMA  WOCKHARDT  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - STRIDES PHARMA SCIENCE COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS